Five Experts Talk End of Life Psychedelic Care

EOLPC brought together 5 experts in the field of psychedelic and end of life care: a cancer survivor, EoL Doula, Palliative Care Physician, Psychiatrist, and Chaplain.

A resource by End of Life Psychedelic Care

display description

On August 28, EOLPC hosted an Open Forum with Palliative Care Physician, Dr. Michael Fratkin. Members of the community came together to ask their questions about the use of psychedelics to help those with life-threatening or terminal illnesses. The questions that arose were wide-ranging and deserve further discussion. There is much we still do not know about how psychedelics help ease anxiety and depression and overcome the fear of dying.

On December 8, EOLPC hosted a second Open Forum bringing together a panel of experts who will share their collective knowledge and experience to answer as many questions as possible.

Moderator: Christine Caldwell, Founder and Executive Director for the nonprofit End of Life Psychedelic Care

Panelists: Dr. Michael Fratkin, Palliative Care Physician and Ketamine Therapy Provider;Dr. Matt Brown, Psychiatrist, Certified Psychedelic Therapist and Ketamine Therapy Provider; Thomas Hartle, 8 year Stage 4 colon cancer survivor and experienced psilocybin journeyer; Mary Telliano, End of Life Doula and experienced Psychedelic Journey Facilitator; and Laura (LB) Barry, Hospice Chaplain and experienced Psychedelic Journey Facilitator

Even if you missed the initial session, this follow up will definitely be enlightening and one that will continue to advance the conversation around building a more compassionate approach to helping people faced with a life-threatening or terminal diagnosis.

Our Inspiration

The questions are sometimes more important to understand than the answers. EOLPC hosted an Open Forum where the community asked the questions top of mind when asked about end of life and psychedelic care. I felt it was important to bring together those individuals most involved in the field to share their collective knowledge. This included an 8 year cancer survivor who attributes psilocybin with enabling him to face a Stage 4 colon cancer diagnosis and thrive to experienced facilitators serving people toward the end of life, and two medical professionals. Each brought a critical perspective to the conversation of end of life and psychedelic care.

Other resources you may like